Skip to main content
. 2008 May 16;8:50. doi: 10.1186/1472-6750-8-50

Figure 2.

Figure 2

Clearance of BChE/hSA fusion protein produced in vitro (A) and a transgenically produced BChE preparation containing >70% tetramer (B) in juvenile pigs in vivo. Juvenile pigs were injected i.v. with the proteins and plasma BChE activity (%) above control (untreated pigs, ~1.6 unit/ml) was plotted versus time (hours) for each animal.